Kelsey Financial’s Pfizer PFE Stock Holding History

Kelsey Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	9,476 +1,003	+12%	+$26.2K	0.17%	56
2026 Q1	$238K	Buy	+8,473	New	+$226K	0.21%	53

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kelsey Financial's PFE Position: Q2 2026 in Review

Kelsey Financial increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $26.2K and bringing the position to 9,476 shares worth $228K. The position accounts for 0.17% of the portfolio, ranked #56.

Kelsey Financial first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $238K in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kelsey Financial held 9,476 shares of Pfizer worth $228K as of Q2 2026.
Kelsey Financial bought 1,003 Pfizer shares in Q2 2026, an estimated $26.2K.
Pfizer made up 0.17% of Kelsey Financial's portfolio in Q2 2026, its #56 holding.
Kelsey Financial first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Kelsey Financial's Pfizer position peaked at $238K in Q1 2026.
2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kelsey Financial's 13F filing for Q2 2026, filed 10 Aug 2026.